PROLENE: payments to doctors
Payments that named PROLENE as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 1,993
- Transactions
- 3,302
- Average per transaction
- $326
The per-transaction average — $326 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,993 providers the average total is $540, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $644,172 | 59.8% |
| Medical Device Business Services, Inc. | $394,524 | 36.6% |
| Ethicon Endo-surgery Inc. | $37,701 | 3.5% |
| Mentor Worldwide LLC | $172 | 0.0% |
| Johnson And Johnson International | $14 | 0.0% |